Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03944304
Recruitment Status : Recruiting
First Posted : May 9, 2019
Last Update Posted : July 13, 2020
Sponsor:
Information provided by (Responsible Party):
Yoon-Koo Kang, Asan Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : August 1, 2021